Form 8-K - Current report:
SEC Accession No. 0001645113-23-000004
Filing Date
2023-01-05
Accepted
2023-01-05 07:03:15
Documents
13
Period of Report
2023-01-05
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nvcr-20230105.htm   iXBRL 8-K 34346
2 EX-99.1 specialreportprjanuary2023.htm EX-99.1 15251
  Complete submission text file 0001645113-23-000004.txt   191966

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nvcr-20230105.xsd EX-101.SCH 1999
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nvcr-20230105_lab.xml EX-101.LAB 24053
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nvcr-20230105_pre.xml EX-101.PRE 12577
7 EXTRACTED XBRL INSTANCE DOCUMENT nvcr-20230105_htm.xml XML 10814
Mailing Address NO. 4 THE FORUM GRENVILLE STREET ST. HELIER Y9 JE2 4UF
Business Address NO. 4 THE FORUM GRENVILLE STREET ST. HELIER Y9 JE2 4UF 44 (0)15 3475 6700
NovoCure Ltd (Filer) CIK: 0001645113 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37565 | Film No.: 23509707
SIC: 3841 Surgical & Medical Instruments & Apparatus